Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
What is the basis of immune dysfunction?
|
Inappropriate response to an immunogen.
|
|
6 factors in determining hypersensitivity response
|
1. Genetics
2. Nature of the immunogen 3. Individual variation 4. Dosage of the immunogen 5. Type of immunogen-immune mediators rxn 6. Site of the rxn. |
|
Type I Hypersensitivity-Another name?
Immune reactant? Mech? |
Anaphylactic
IgE Mast cell activation |
|
Type II HS-Another name?
Immune reactant? Mech? |
Cytotoxic
IgG or IgM Antibodies alter signaling |
|
Type III HS-Another name?
Immune reactant? Mech? |
Immune complex
IgG Complement & Phagocytes |
|
Type IV HS-Another name?
|
Delayed (others are immediate) or cell mediated
T-cells |
|
Type I HS-IgE is synthesized by _______ and controlled by _______.
|
B-cell synthesis
Ts-cell control |
|
These are the immediate acting granules released by the mast cells in Type I HS:
|
Histamine
Heparin Proteolytic Enzymes Chemotactic Factors |
|
These are the late acting granules released by the mast cells in Type I HS:
|
Prostaglandins
Thromboxanes SRS Leukotrienes |
|
Delayed (cytokine) pathway of Mast cell granule release is keyed by:
|
Cytosolic Phospholipase A2 Reaction
Arachadonic Acid Takes about one hour |
|
After first encounter with an antigen (sensitizing contact) B-cells produce specific versions of this:
|
IgE (Reagin)
|
|
Appropriate amounts of Epinepherine for a patient in anaphylaxis.
Subcutaneous and Intravenous |
Subc-.1-.5 mL 1:1000 every 10-15 min
Intrav-.1-.25 mL 1:1000 |
|
Clinical tests for allegies
|
Skin-Wheal-flare rxn
Eye-Conjunctivitis Radioallergosorbent Test (RAST)-quantitative test for IgE antibodies in serum |
|
What is hyposensitization?
|
Small dosages of the allergen over time
IgE drops, IgG increases |
|
cAMP does what in anaphylaxis?
What triggers its production? |
It restores balance to the cells.
Epinephrine triggers cAMP. |
|
Cromolyn Sulfate does what?
|
Strengthens mast cell membrane-less granule release.
Only works as a prophylaxis. |
|
Theophylline does what?
|
Blocks phosphodiesterase and thus, increases cAMP
|
|
Ultimate result of Type II hypersens?
|
Cell lysis through IgG or IgM-both can activate the Compl. cascade
|
|
Role of C3b in Type II HS?
|
Marks innocent bystander cells for neutrophil lysis.
|
|
A & B (blood types) are what type of molecules?
|
Glycoproteins
|
|
RhD + and - are what types of molecules?
|
Proteins
|
|
Why do we see Hemolytic disease of newborns with RhD but not with A & B?
|
RhD (IgG)
A & B (IgM)-Doesn't cross placenta |
|
Type III HS-Key
|
Inflammation
|
|
Arthus Reaction
|
Type III HS
Local reaction in and around small vessels (esp. the skin) Local edema, hemorrhage, necrosis |
|
Serum Sickness
|
Type III HS
Systemic Animal serum proteins |
|
Farmers lung and Pigeon Breeder's diseases
|
Type III HS
|